# Amesite Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/Amesite Inc.).

## Overview

Amesite Inc. is a U.S.-based software company that builds AI-driven applications for both consumer and enterprise users. Its current business is centered on NurseMagic™, a mobile healthcare app designed to help nurses create documentation, communicate with patients, and get workflow guidance in post-acute care settings. The company also operates an education platform for professional learning, though recent filings indicate its strategic emphasis has shifted toward healthcare. Amesite was incorporated in 2017 and describes itself as using proprietary AI infrastructure, patents, and configurable deployments to deliver tightly integrated software and services. The company remains early-stage, with limited revenue and ongoing financing needs, and it continues to position its products around rapid deployment and low integration burden.

## Products & services

• NurseMagic™ mobile healthcare app for nursing documentation and guidance
• AI-driven post-acute care workflow and patient communication tools
• Higher-ed professional learning platform
• Amesite Engage learning/community platform
• Hosted software and technology-enabled services subscriptions
• Configurable enterprise deployments with no external integration

- **Healthcare AI software** (70%) — NurseMagic™ and related AI tools for nursing documentation, communication, and workflow support in post-acute care.
- **Education and professional learning** (20%) — The company's higher-ed and professional learning platform used by institutions and learners for online education.
- **Hosted platform services** (10%) — Recurring hosted software and technology-enabled services delivered under customer contracts over time.

- NurseMagic™ mobile healthcare app
- AI-driven nursing notes and documentation automation
- Patient communication and care guidance tools
- Higher-ed professional learning platform
- Amesite Engage learning/community platform
- Hosted SaaS and technology-enabled services
- Configurable enterprise deployments without external integration

## Customers

Amesite sells to both individual users and organizations, with recent filings showing a clear pivot toward healthcare. On the consumer side, individual nurses use NurseMagic™ to speed up note-taking, documentation, and day-to-day clinical support. On the enterprise side, post-acute care organizations such as skilled nursing, assisted living, memory care, home health, and rehabilitation providers buy the product to improve staff productivity and standardize workflows. The company also has legacy or secondary customers in education and professional learning, including institutions and other organizations that use its hosted learning platform. Management emphasizes that the product is designed for simple deployment and configurable workflows, which matters to buyers that want fast adoption without complex IT integration.

- **Individual nurses** (primary) — Buy NurseMagic™ directly for documentation help, patient communication support, and practical guidance in daily work.
- **Post-acute care enterprises** (primary) — Skilled nursing, assisted living, memory care, home health, and rehabilitation organizations buy the app to improve staff efficiency and standardize care workflows.
- **Healthcare administrators and operators** (secondary) — Decision-makers who evaluate ROI, compliance, and ease of deployment before rolling out the platform across teams.
- **Education and professional learning customers** (secondary) — Institutions and organizations using Amesite's learning platform for online training and professional development.

- Individual nurses who want faster documentation and clinical support
- Post-acute care operators seeking workflow efficiency and staff productivity
- Skilled nursing and assisted living facilities buying documentation tools
- Home health and rehabilitation providers needing mobile care support
- Education and professional learning customers using hosted platforms
- Organizations that value quick deployment and minimal integration effort

## Geography

Amesite is headquartered in the United States and its filings are written as those of a U.S. public company. The available excerpts do not disclose a formal geographic revenue split, and the business appears to be primarily U.S.-focused based on its healthcare and education customer base. Because NurseMagic™ targets regulated U.S. healthcare settings, domestic compliance requirements such as HIPAA and CMS rules are central to operations. The company also references GDPR in its risk disclosures, indicating that privacy and data rules outside the U.S. could matter if it expands internationally or handles cross-border data. At present, geography matters more as a regulatory and market-access issue than as a manufacturing or supply-chain footprint.

- United States is the core operating and customer market
- Healthcare compliance exposure is tied to U.S. federal and state rules
- Education and professional learning customers are also primarily U.S.-based
- GDPR is mentioned as a potential privacy regime if international exposure grows
- No manufacturing footprint is disclosed; business is software-delivery based

## Strategy

Amesite's current strategy is to concentrate resources on NurseMagic™ and the healthcare market rather than spreading investment across multiple product lines. Management says the app is designed for rapid deployment, no external integration, and configurable workflows, which supports faster adoption in post-acute care. The company is also trying to build traction in both B2C and B2B channels, using individual nurses and enterprise customers to expand market reach. At the same time, Amesite has defocused on academic customers and is not dedicating resources to growing Amesite Engage, suggesting a narrower product and capital allocation strategy. This focus is meant to improve commercialization efficiency and reduce cash burn, but it also increases dependence on one core product and one end market.

- **Scale NurseMagic™ adoption in post-acute care** (short-term) — The company is concentrating on the product with the clearest commercial traction and the most direct healthcare use case.
- **Maintain low-friction deployment and configurability** (short-term) — Ease of onboarding and minimal integration are central to adoption in healthcare organizations with limited IT tolerance.
- **Improve cash discipline and funding flexibility** (short-term) — The company is not profitable and continues to face going-concern uncertainty, so capital access is critical.
- **Build a defensible AI product moat** (medium-term) — Patents, proprietary infrastructure, and trade secrets are intended to support differentiation in a competitive market.

- Concentrate development and sales on NurseMagic™
- Target post-acute healthcare where AI documentation tools can show clear ROI
- Use both B2C and B2B go-to-market motions
- Keep deployments simple with no external system integration
- Offer configurable features to fit customer workflows
- Reduce emphasis on academic customers and Amesite Engage
- Preserve cash through disciplined spending and narrower product focus

## Risks

Amesite faces substantial execution risk because it is still building a recurring revenue base while competing against larger healthcare software vendors and AI-first entrants. Its NurseMagic™ product operates in a heavily regulated environment, so failures in HIPAA, CMS, privacy, or emerging AI compliance could trigger penalties, customer loss, or reputational damage. The company also depends on adoption by nurses and healthcare organizations, and market acceptance could be slowed by organizational inertia, integration concerns, or skepticism about AI in clinical settings. Financially, the business remains unprofitable and has disclosed substantial doubt about its ability to continue as a going concern, making access to external financing a key risk. More broadly, macro weakness in healthcare IT spending, cybersecurity incidents, and rapid changes in AI regulation could all pressure growth and operating continuity.

- **Going-concern and financing dependence** [critical] — The company is not profitable and says its financing plans may not be sufficient or within its control.
- **Healthcare regulatory compliance** [high] — NurseMagic™ is used in regulated post-acute settings where privacy, documentation, and care standards matter.
- **AI adoption and competitive pressure** [high] — Customers may prefer established vendors or delay adoption of AI tools in clinical workflows.
- **Cybersecurity and data breach exposure** [high] — The platform processes sensitive health and personal data, making breaches potentially costly and damaging.

- Going-concern and financing risk due to ongoing losses and limited cash generation
- Healthcare regulatory risk from HIPAA, CMS, HITECH, and privacy laws
- AI compliance risk as transparency, bias, and cybersecurity rules evolve
- Competitive risk from larger software platforms and better-funded AI entrants
- Adoption risk if nurses or healthcare operators do not see clear ROI
- Cybersecurity and data protection risk because the product handles health-related information
- Macro spending risk if healthcare or IT budgets tighten

## Accounting

Amesite's revenue is recognized ratably over the contract term, generally one month, because its hosted platform and technology-enabled services are delivered over time. That means reported revenue can lag or smooth customer activity, and deferred revenue balances are important for understanding future recognized revenue. The company also capitalizes internally developed software costs during the application development stage and amortizes them over an estimated useful life of about three years, so management judgment affects both asset values and operating expense timing. Because the company is small and early-stage, quarter-to-quarter results can be volatile and heavily influenced by contract timing, customer onboarding, and development spending. Investors should also watch the going-concern disclosure, since financing assumptions and liquidity judgments can materially affect the presentation of the financial statements.

- **Revenue recognition over time** — Affects revenue smoothing and deferred revenue balances
- **Deferred revenue** — Important for assessing near-term revenue visibility
- **Capitalized software development costs** — Affects operating expenses, intangible assets, and amortization
- **Going-concern assessment** — Material to solvency and financial statement interpretation

- Revenue is recognized ratably over the service period, affecting timing of reported sales
- Deferred revenue reflects future service obligations and indicates unrecognized contracted revenue
- Capitalized software costs are amortized over an estimated useful life, affecting EBITDA-like margins
- Judgment is required to determine when software development enters the capitalization stage
- Going-concern assumptions depend on financing plans and cash forecasts
- Small revenue base can create large quarter-to-quarter comparability swings

---

*Last updated: 2026-08-11T04:46:20.825442+00:00*